{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:57Z","timestamp":1772165697935,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-024-03895-2","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T05:18:08Z","timestamp":1751347088000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A case of chronic myelomonocytic related lysozyme-induced nephropathy"],"prefix":"10.1186","volume":"26","author":[{"given":"Abhik","family":"Kansal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanushi","family":"Peiris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaineel","family":"Ramnarain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simin","family":"Daneshvar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaun","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"3895_CR1","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s13730-020-00567-6","volume":"10","author":"M Asano","year":"2021","unstructured":"Asano M, Hase H, Naruse Y, Kawada K, Kojima I, Branch J, et al. A rare cause of acute kidney injury with chronic myelomonocytic leukemia. CEN Case Rep. 2021;10:320\u20135.","journal-title":"CEN Case Rep"},{"key":"3895_CR2","doi-asserted-by":"crossref","unstructured":"\u200bPatel AB, Miles RR, Deininger MW. Lysozyme nephropathy in chronic myelomonocytic leukemia. Clin Case Rep. 2019;7:1263\u20134.","DOI":"10.1002\/ccr3.2188"},{"key":"3895_CR3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/nep.13056","volume":"23","author":"TL Goh","year":"2018","unstructured":"Goh TL, Carpenter L, Ly E. Lysozyme Nephropathy in Haematologically Stable Chronic Myelomonocytic Leukaemia. Nephrology. 2018;23:377\u2013377.","journal-title":"Nephrology."},{"key":"3895_CR4","unstructured":"Hillen JM, Raemaekers JM, Steenbergen EJ, Wetzels JFM, Verhave JC. Progressive kidney failure in chronic myelomonocytic leukaemia: don\u2019t forget lysozyme damage. NJM. 2018."},{"key":"3895_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/bjh.16455","volume":"189","author":"A Maraj","year":"2020","unstructured":"Maraj A, MacEneaney O, Doyle B, Quinn J. Lysozyme-induced nephropathy: a rare manifestation of chronic myelomonocytic leukaemia. Br J Haematol. 2020;189:393\u2013393.","journal-title":"Br J Haematol."},{"key":"3895_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ekir.2016.09.002","volume":"2","author":"D Santoriello","year":"2017","unstructured":"Santoriello D, Andal LM, Cox R, D\u2019Agati VD, Markowitz GS. Lysozyme-Induced Nephropathy. Kidney Int Rep. 2017;2:84\u20138.","journal-title":"Kidney Int Rep"},{"key":"3895_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1053\/j.ajkd.2008.11.013","volume":"54","author":"TV Patel","year":"2009","unstructured":"Patel TV, Rennke HG, Sloan JM, DeAngelo DJ, Charytan DM. A Forgotten Cause of Kidney Injury in Chronic Myelomonocytic Leukemia. Am J Kidney Dis. 2009;54:159\u201364.","journal-title":"Am J Kidney Dis"},{"key":"3895_CR8","first-page":"1","volume":"9","author":"J Spapen","year":"2015","unstructured":"Spapen J, Fostier K, Raeve HD, Janssens P, Spapen H. An unexpected complication of chronic myelomonocytic leukemia: severe renal failure due to malignant tubulo-interstitial cell infiltration. Int J Nephrol Renov Dis. 2015;9:1\u20134.","journal-title":"Int J Nephrol Renov Dis"},{"key":"3895_CR9","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.kint.2020.06.028","volume":"99","author":"I Mohamadou","year":"2021","unstructured":"Mohamadou I, Buob D, Rabant M, Pichon J, Gaudry S, Luque Y, et al. The Case | Acute kidney injury associated with chronic myelomonocytic leukemia. Kidney Int. 2021;99:495\u20136.","journal-title":"Kidney Int"},{"key":"3895_CR10","doi-asserted-by":"crossref","unstructured":"\u200bKudose S, Cossey LN, Canetta PA, Sekulic M, Vanbeek CA, Huls FB, et al. Clinicopathologic Spectrum of Lysozyme-Associated Nephropathy. Kidney Int Rep. 2023;8:1585\u201395.","DOI":"10.1016\/j.ekir.2023.05.007"},{"key":"3895_CR11","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.3390\/antibiotics10121534","volume":"10","author":"P Ferraboschi","year":"2021","unstructured":"Ferraboschi P, Ciceri S, Grisenti P. Applications of lysozyme, an innate immune defense factor, as an alternative antibiotic. Antibiotics. 2021;10:1534.","journal-title":"Antibiotics"},{"key":"3895_CR12","first-page":"e34344","volume":"15","author":"N Paulo","year":"2023","unstructured":"Paulo N, Baptista P, Nogueira F, Pereira C, Cerqueira A, Rocha A. Lysozyme-induced nephropathy: a diagnosis not to forget. Cureus. 2023;15:e34344.","journal-title":"Cureus"},{"key":"3895_CR13","first-page":"210","volume":"30","author":"T Borges","year":"2016","unstructured":"Borges T, R\u00eago I, Badas J, Marques S, Ferreira H, Pinto R, et al. Chronic myelomonocytic leukaemia: a presentation with rare extramedullary involvement. Port J Nephrol Hypertens. 2016;30:210\u20136.","journal-title":"Port J Nephrol Hypertens"},{"key":"3895_CR14","doi-asserted-by":"crossref","unstructured":"\u200bPruzanski W, Platts ME. Serum and urinary proteins, lysozyme (muramidase), and renal dysfunction in mono- and myelomonocytic leukemia. J Clin Investig. 1970;49:1694\u2013708.","DOI":"10.1172\/JCI106387"},{"key":"3895_CR15","doi-asserted-by":"crossref","unstructured":"Perazella MA, Eisen RN, Frederick WG, Brown E. Renal Failure and Severe Hypokalemia Associated With Acute Myelomonocytic Leukemia. Am J Kidney Dis. 1993;22:462\u20137.","DOI":"10.1016\/S0272-6386(12)70154-3"},{"key":"3895_CR16","doi-asserted-by":"crossref","unstructured":"\u200bSehmbey GS, Abraham J. Lysozyme Toxicity Causing Proximal Tubulopathy in Patient with Acute Monocytic Leukemia. In: American Society of Nephrology Kidney Week. Pennsylvania; 2023.","DOI":"10.1681\/ASN.20233411S1479a"},{"issue":"2","key":"3895_CR17","doi-asserted-by":"publisher","first-page":"100769","DOI":"10.1016\/j.xkme.2023.100769","volume":"6","author":"RM Attieh","year":"2024","unstructured":"Attieh RM, Begum F, Chitty D, Izzedine H, Jhaveri KD. Kidney and Urinary Tract Involvement in Chronic Myelomonocytic Leukemia. Kidney Med. 2024;6(2): 100769.","journal-title":"Kidney Med"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03895-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03895-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03895-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T05:18:10Z","timestamp":1751347090000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03895-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3895"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03895-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4419359\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"14 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from Epworth Research Development and Governance Unit, reference number EH2023-1057.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from our patient and is available upon request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"302"}}